Donnie McGrath

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

Jean‐Michel Molina, Jaime Andrade‐Villanueva, Juan Echevarría et al. · The Lancet · 2008 · 482 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1–Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study

Jean‐Michel Molina, Jaime Andrade‐Villanueva, Juan Echevarría et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 255 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

Daniel R Malan, Edrich Krantz, Neal David et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 150 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naïve Subjects in the CASTLE Study

Max Lataillade, Jennifer Chiarella, Rong Yang et al. · PLoS ONE · 2010 · 130 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Adenovirus Infection in Adult Orthotopic Liver Transplant Recipients: Incidence and Clinical Significance

Donnie McGrath, Matthew E. Falagas, Richard B. Freeman et al. · The Journal of Infectious Diseases · 1998 · 105 citations

Medicine, Infectious Diseases, Pediatrics +14